Feature

Measles outbreak in New York City has ended


 

The measles outbreak in New York City, the largest in the nation this year, has officially ended, Mayor Bill de Blasio and city health officials announced Sept. 3.

Measles viron CDC/ Cynthia S. Goldsmith; William Bellini, Ph.D.

“Ending the measles outbreak required extensive collaboration with community organizations and Jewish leaders. They helped encourage vaccinations and achieve record immunization levels in parts of Brooklyn,” Mayor de Blasio said in a written statement. “As we head back to school this week, we just remain vigilant. To keep our children and communities safe, I urge all New Yorkers to get vaccinated. It’s the best defense we have.”

A measles outbreak is considered to be over when 42 days, or two incubation periods, have elapsed since the last affected persons in the area were no longer infectious. “That time period has now passed for the people most recently infected with measles and reported,” the city health department said in the statement.

Since the outbreak began in October of last year, 654 individuals were diagnosed with measles in the five boroughs of New York, although 72% occurred in the Williamsburg neighborhood of Brooklyn. Of those 654 cases, there have been 52 hospitalizations and 16 admissions to intensive care, according to the health department. The majority of affected people were under 18 years of age (80%), and most were either unvaccinated (73%) or incompletely vaccinated (7%).

The end of the measles outbreak also brings an end to the public health emergency that was declared on April 9 for parts of Brooklyn, the statement noted.

“Vaccination coverage has increased significantly since the emergency order, which has been supported by community-led efforts. We are grateful to the New Yorkers who shared the truth about vaccines and protected the health of their friends and neighbors through this outbreak,” city health commissioner Dr. Oxiris Barbot said in the statement.

Recommended Reading

Recombinant vaccine cut herpes zoster rate in immunocompromised patients
MDedge Dermatology
Cellulitis ranks as top reason for skin-related pediatric inpatient admissions
MDedge Dermatology
Measles cases have slowed but not stopped
MDedge Dermatology
New measles outbreaks reported in Los Angeles and El Paso
MDedge Dermatology
FDA approvals permit double-immunoassay approach to Lyme disease diagnosis
MDedge Dermatology
Too many blood cultures ordered for pediatric SSTIs
MDedge Dermatology
Favorable Ebola results lead to drug trial termination, new focus
MDedge Dermatology
New measles outbreak reported in western N.Y.
MDedge Dermatology
Fifty-one percent of U.S. adolescents fully vaccinated against HPV
MDedge Dermatology
Cephalosporins remain empiric therapy for skin infections in pediatric AD
MDedge Dermatology